Welcome!

SYS-CON UK Authors: Salvatore Genovese, Jamie Matusow

News Feed Item

Alere to Attend the 31st Annual J.P. Morgan Healthcare Conference on January 9, 2013

WALTHAM, Mass., Dec. 28, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information technology, announced today that it will attend the 31st Annual J.P. Morgan Healthcare Conference being held January 7 – 10, 2013 at the Westin St. Francis Hotel in San Francisco.  Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend.  Mr. Zwanziger's presentation is scheduled for Wednesday, January 9, 2013 at 10:00 a.m. PST and will be made available to the public through a webcast accessible via http://jpmorgan.metameetings.com/webcasts/healthcare13/directlink?ticker=ALR, as well as through the company's website at http://www.alere.com/us/en/about/investor-relations/events.html

A replay of the webcast will be available via the links above for approximately 30 days from the date of the webcast.  During his presentation, Mr. Zwanziger may discuss and answer questions concerning business and financial developments and trends.  His responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

About Alere
By developing new capabilities in near-patient diagnosis, monitoring and health information technology, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology and diabetes. Alere is headquartered in Waltham, Massachusetts.  For more information regarding Alere, please visit www.alere.com.   

SOURCE Alere Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.